Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone to prevent progression of vascular calcification in peritoneal dialysis patients
TCTR20221207001Phase 3Completed
- Sponsor
- Navamindradhiraj University Research Fund
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of spironolactone in arterial calcification, sponsored by Navamindradhiraj University Research Fund. Started May 2019; status: completed.
02
Drugs
spironolactone
03
Conditions
arterial calcification
Beyond the preview
Go deeper on TCTR20221207001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221207001.